|
Index of reports
> Cases resulting in disability (39)
> Cases with Blood Creatine Phosphokinase Increased (8)
Below is the selection of adverse event reports related to Zetia (Ezetimibe) that includes cases resulting in disability where reactions include blood creatine phosphokinase increased.
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-10-17
Patient: male, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Weight Decreased, Blood Creatine Phosphokinase Increased, Muscle Atrophy, Muscle Contractions Involuntary, Fear, Myalgia, Facial Paresis, Joint Range of Motion Decreased, Amyotrophic Lateral Sclerosis, Blood Cholesterol Increased, Dyspnoea, Pain in Extremity, Chromaturia, Anxiety, Hyperphagia, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypercholesterolaemia
Lipitor
Indication: Blood Cholesterol Increased
Zetia
Other drugs received by patient: Norvasc; Metoprolol
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-06-29
Patient: male, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Weight Decreased, Muscle Atrophy, Blood Creatine Phosphokinase Increased, Fear, Myalgia, Facial Paresis, Joint Range of Motion Decreased, Amyotrophic Lateral Sclerosis, Blood Cholesterol Increased, Dyspnoea, Pain in Extremity, Chromaturia, Anxiety, Hyperphagia, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypercholesterolaemia
Lipitor
Indication: Blood Cholesterol Increased
Zetia
Other drugs received by patient: Norvasc; Metoprolol Succinate
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-06-25
Patient: male, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Weight Decreased, Muscle Atrophy, Blood Creatine Phosphokinase Increased, Dyspnoea, Pain in Extremity, Fear, Myalgia, Anxiety, Facial Paresis, Hyperphagia, Joint Range of Motion Decreased, Amyotrophic Lateral Sclerosis, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypercholesterolaemia
Lipitor
Indication: Blood Cholesterol Increased
Zetia
Other drugs received by patient: Norvasc; Metoprolol Succinate
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-05-22
Patient: male, weighing 79.8 kg (175.6 pounds)
Adverse reactions / side effects: Weight Decreased, Muscle Atrophy, Blood Creatine Phosphokinase Increased, Dyspnoea, Pain in Extremity, Fear, Myalgia, Facial Paresis, Hyperphagia, Joint Range of Motion Decreased, Amyotrophic Lateral Sclerosis, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Indication: Hypercholesterolaemia
Lipitor
Indication: Blood Cholesterol Increased
Zetia
Other drugs received by patient: Norvasc; Metoprolol Succinate
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-05-07
Patient: male
Adverse reactions / side effects: Myalgia, Weight Decreased, Blood Creatine Phosphokinase Increased, Muscle Atrophy, Asthenia, Disability, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Suspect drug(s):
Lipitor
Indication: Hypercholesterolaemia
Zetia
Adverse event in 42 year old male receiving Zetia (Ezetimibe)
Reported by a physician from United Arab Emirates on 2007-04-18
Patient: 42 year old male, weighing 162.0 kg (356.4 pounds)
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Hepatic Enzyme Increased
Adverse event resulted in: disablity
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-02-07
Patient: male
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Muscular Weakness
Adverse event resulted in: disablity
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in 71 year old female receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-01-22
Patient: 71 year old female, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Drug Interaction
Adverse event resulted in: disablity
Suspect drug(s):
Atorvastatin Calcium
Indication: Blood Cholesterol Increased
Start date: 2005-03-18
End date: 2006-02-24
Zetia
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2005-11-10
End date: 2006-01-26
Other drugs received by patient: Vaseretic; Nifedipine; Doxazosin Mesylate; Venlafaxine Hydrochloride; Omeprazole
|
